GR3021804T3 - Indole derivatives as 5-h1-like agonists for use in migraine - Google Patents
Indole derivatives as 5-h1-like agonists for use in migraineInfo
- Publication number
- GR3021804T3 GR3021804T3 GR960403195T GR960403195T GR3021804T3 GR 3021804 T3 GR3021804 T3 GR 3021804T3 GR 960403195 T GR960403195 T GR 960403195T GR 960403195 T GR960403195 T GR 960403195T GR 3021804 T3 GR3021804 T3 GR 3021804T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- migraine
- agonists
- indole derivatives
- date oct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939308360A GB9308360D0 (en) | 1993-04-22 | 1993-04-22 | Indoles |
GB939324433A GB9324433D0 (en) | 1993-11-27 | 1993-11-27 | Indoles |
PCT/EP1994/001121 WO1994024127A1 (en) | 1993-04-22 | 1994-04-11 | Indole derivatives as 5-h1-like agonists for use in migraine |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3021804T3 true GR3021804T3 (en) | 1997-02-28 |
Family
ID=26302791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960403195T GR3021804T3 (en) | 1993-04-22 | 1996-11-28 | Indole derivatives as 5-h1-like agonists for use in migraine |
Country Status (21)
Country | Link |
---|---|
US (1) | US5607960A (el) |
EP (1) | EP0695301B1 (el) |
JP (1) | JP2802169B2 (el) |
KR (1) | KR960701865A (el) |
CN (1) | CN1121348A (el) |
AT (1) | ATE144773T1 (el) |
AU (1) | AU6567094A (el) |
BR (1) | BR9406481A (el) |
CA (1) | CA2157397C (el) |
CZ (1) | CZ274595A3 (el) |
DE (1) | DE69400824T2 (el) |
DK (1) | DK0695301T3 (el) |
ES (1) | ES2094653T3 (el) |
FI (1) | FI954944A0 (el) |
GR (1) | GR3021804T3 (el) |
HU (1) | HUT73807A (el) |
IL (1) | IL109337A0 (el) |
NO (1) | NO954168D0 (el) |
NZ (1) | NZ265269A (el) |
PL (1) | PL311204A1 (el) |
WO (1) | WO1994024127A1 (el) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
KR100191973B1 (ko) * | 1993-08-31 | 1999-06-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 5-아릴인돌 유도체 |
GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9420503D0 (en) * | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
MX9706969A (es) * | 1995-03-20 | 1997-11-29 | Lilly Co Eli | 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos. |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
AU4074897A (en) * | 1996-09-18 | 1998-04-14 | Eli Lilly And Company | A method for the prevention of migraine |
EP0944595B1 (en) * | 1996-11-26 | 2003-10-01 | NPS Allelix Corp. | 5-cyclo indole compounds as 5-ht1d receptor ligands |
US5998462A (en) * | 1996-12-16 | 1999-12-07 | Allelix Biopharmaceuticals Inc. | 5-alkyl indole compounds |
US5856510A (en) * | 1996-12-16 | 1999-01-05 | Allelix Biopharmaceuticals Inc. | 5-alkenyl and 5-alkynyl indole compounds |
GB9705035D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
EP0875513A1 (en) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituted heteroaromatic 5-HT 1F agonists |
CA2299286A1 (en) | 1997-08-09 | 1999-02-18 | Laramie Mary Gaster | Bicyclic compounds as ligands for 5-ht1 receptors |
US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
WO2000000490A2 (en) * | 1998-06-26 | 2000-01-06 | Eli Lilly And Company | 5-ht1f agonists |
US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
AU2001281738B2 (en) | 2000-07-21 | 2006-12-21 | H.Lundbeck A/S | Indole derivatives useful for the treatment of cns disorders |
US6489512B1 (en) * | 2002-06-21 | 2002-12-03 | Rhodia Chirex Inc. | Method for making aryl hydrazines and substituted indoles |
CA2509225C (en) * | 2002-12-10 | 2011-09-20 | Guenter Hoelzemann | Indol derivatives and their use as 5-ht ligands |
JP4897221B2 (ja) * | 2002-12-20 | 2012-03-14 | チバ ホールディング インコーポレーテッド | アミン類の合成及びその合成のための中間体 |
US7332183B2 (en) * | 2002-12-26 | 2008-02-19 | Pozen Inc. | Multilayer dosage forms containing NSAIDs and triptans |
WO2004110492A2 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and nsaids |
US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
GB0807772D0 (en) * | 2008-04-29 | 2008-06-04 | Lectus Therapeutics Ltd | Calcium ion modulators and uses thereof |
FR2953720B1 (fr) * | 2009-12-11 | 2012-05-11 | Oreal | Utilisation de derives de benzyloxy-ethylamines comme conservateur, |
CN104557957B (zh) * | 2013-10-09 | 2017-04-19 | 华东师范大学 | 螺‑氧化吲哚环氧乙烷衍生物的合成方法 |
MX2022009528A (es) * | 2020-02-04 | 2022-11-14 | Mindset Pharma Inc | Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8530507D0 (en) * | 1985-12-11 | 1986-01-22 | Glaxo Group Plc | Chemical compounds |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
RU2095360C1 (ru) * | 1990-10-15 | 1997-11-10 | Пфайзер Инк. | Производные индола, их оптические изомеры и фармацевтически приемлемые соли |
-
1994
- 1994-04-11 CA CA002157397A patent/CA2157397C/en not_active Expired - Fee Related
- 1994-04-11 CN CN94191850A patent/CN1121348A/zh active Pending
- 1994-04-11 KR KR1019950704623A patent/KR960701865A/ko not_active Application Discontinuation
- 1994-04-11 HU HU9501920A patent/HUT73807A/hu unknown
- 1994-04-11 US US08/532,573 patent/US5607960A/en not_active Expired - Fee Related
- 1994-04-11 NZ NZ265269A patent/NZ265269A/en unknown
- 1994-04-11 BR BR9406481A patent/BR9406481A/pt not_active Application Discontinuation
- 1994-04-11 DK DK94913573.5T patent/DK0695301T3/da active
- 1994-04-11 PL PL94311204A patent/PL311204A1/xx unknown
- 1994-04-11 DE DE69400824T patent/DE69400824T2/de not_active Expired - Fee Related
- 1994-04-11 CZ CZ952745A patent/CZ274595A3/cs unknown
- 1994-04-11 JP JP6522726A patent/JP2802169B2/ja not_active Expired - Fee Related
- 1994-04-11 AU AU65670/94A patent/AU6567094A/en not_active Abandoned
- 1994-04-11 ES ES94913573T patent/ES2094653T3/es not_active Expired - Lifetime
- 1994-04-11 AT AT94913573T patent/ATE144773T1/de not_active IP Right Cessation
- 1994-04-11 WO PCT/EP1994/001121 patent/WO1994024127A1/en not_active Application Discontinuation
- 1994-04-11 EP EP94913573A patent/EP0695301B1/en not_active Expired - Lifetime
- 1994-04-18 IL IL10933794A patent/IL109337A0/xx unknown
-
1995
- 1995-10-17 FI FI954944A patent/FI954944A0/fi not_active Application Discontinuation
- 1995-10-19 NO NO954168A patent/NO954168D0/no unknown
-
1996
- 1996-11-28 GR GR960403195T patent/GR3021804T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1121348A (zh) | 1996-04-24 |
DE69400824T2 (de) | 1997-03-13 |
PL311204A1 (en) | 1996-02-05 |
EP0695301A1 (en) | 1996-02-07 |
ATE144773T1 (de) | 1996-11-15 |
HU9501920D0 (en) | 1995-09-28 |
FI954944A (fi) | 1995-10-17 |
HUT73807A (en) | 1996-09-30 |
CZ274595A3 (en) | 1996-03-13 |
BR9406481A (pt) | 1996-01-09 |
DE69400824D1 (de) | 1996-12-05 |
IL109337A0 (en) | 1994-07-31 |
CA2157397A1 (en) | 1994-10-27 |
US5607960A (en) | 1997-03-04 |
CA2157397C (en) | 1999-07-06 |
EP0695301B1 (en) | 1996-10-30 |
JPH08507083A (ja) | 1996-07-30 |
AU6567094A (en) | 1994-11-08 |
ES2094653T3 (es) | 1997-01-16 |
KR960701865A (ko) | 1996-03-28 |
JP2802169B2 (ja) | 1998-09-24 |
NO954168L (no) | 1995-10-19 |
NO954168D0 (no) | 1995-10-19 |
WO1994024127A1 (en) | 1994-10-27 |
DK0695301T3 (da) | 1996-12-09 |
FI954944A0 (fi) | 1995-10-17 |
NZ265269A (en) | 1996-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3021804T3 (en) | Indole derivatives as 5-h1-like agonists for use in migraine | |
GR3019198T3 (en) | Indole derivatives which inhibit leukotriene biosynthesis. | |
FI970148A0 (fi) | Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina | |
ES2121193T3 (es) | Derivados de bencimidazoles. | |
HU9503986D0 (en) | Perhydroisoindole derivatives as p substance antagonists | |
ES2138364T3 (es) | Procedimiento para el almacenamiento reversible de hidrogeno. | |
PL327735A1 (en) | Novel substituted derivatives of imidazole | |
ZA957329B (en) | Topical ketoconazole emulsions | |
DK0772604T3 (da) | Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander | |
AU4310097A (en) | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists | |
ES2185660T3 (es) | Nuevo uso de dexmedetomidina. | |
YU18801A (sh) | Eletriptan hidrobromid monohidrat | |
ATE197453T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
YU26001A (sh) | Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora | |
AU3267097A (en) | Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use | |
MY132066A (en) | Pyrrolidinylmethylindole salt. | |
ES2181791T3 (es) | Derivados de indol para el tratamiento de la migraña. | |
MY108739A (en) | Imidazole, triazole and tetrazole derivatives | |
IL126548A0 (en) | Use of aspirochlorine or derivatives thereof as immunosuppressive agents |